Stock Movers: Novo Nordisk Obesity Pill, Huntington Ingalls Warships, Warner Bros Bidding War

Novo Nordisk Obesity Pill Approval

• 💊 Novo Nordisk shares surged 7% following the approval to sell a pill version of its obesity shot Wegovy in the US.
• 🗓️ The pill will be available in early January, timed for New Year's resolutions, and will cost approximately $150 per month for cash-paying customers.
• 🚀 This approval gives Novo Nordisk a significant head start over competitor Eli Lilly, whose own pill version is expected in March.
• 📉 Despite recent good news, Novo Nordisk shares are down 44% this year, largely due to losing market share to Eli Lilly, which is up 40%.

Huntington Ingalls Warship Development

• 🚢 Huntington Ingalls shares rose 5% pre-market following President Trump's announcement of a new "Trump-class" battleship and a new frigate for the Navy.
• ⚓ The company, a military contractor and shipbuilder, will be responsible for constructing these new vessels, including the frigate dubbed the FFX.
• ⚠️ This announcement comes about a month after the Navy reduced orders for the previous Constellation class frigates, which had faced numerous troubles.
• 🏭 While production is likely a long way off, the new ships are slated to be built at Huntington Ingalls' Newport News Shipyard in Virginia.

Warner Bros. Discovery Bidding War

• 🤝 Warner Bros. Discovery shares saw a slight increase amidst an ongoing bidding war for the company.
• 💰 Larry Ellison has personally backed Paramount's Skydance Corp. bid, which offers $30 per share for the entire company.
• 🎬 Warner Bros. management, however, continues to recommend Netflix's offer of $27.75 per share, which would allow Warner to spin off cable networks before the deal, potentially unlocking more shareholder value.
• ⚖️ The differing offers and recommendations create a complex and shifting takeover battle.